Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
ONSIW was delisted on the 3rd of December, 2018.
9 hedge funds and large institutions have $130K invested in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
10% less funds holding
Funds holding: 10 → 9 (-1)
76% less capital invested
Capital invested by funds: $542K → $130K (-$412K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$4.34K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$1.42K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.01K |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$38 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$80K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$23K |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.19K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $51K | – | – | – |
|
|
ACA
2
Avoro Capital Advisors
New York
| $28K | – | – | – |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $18K | -$23K | -179,818 | -53% |
|
|
ACP
4
Acuta Capital Partners
Redwood City,
California
| $12K | – | – | – |
|
|
PC
5
PointState Capital
New York
| $12K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| $4K | +$4.34K | +33,928 | New |
|
|
MIM
7
Monashee Investment Management
Boston,
Massachusetts
| $3K | -$3.19K | -25,000 | Closed |
|
|
8
UBS Group
Zurich,
Switzerland
| $1K | +$1.01K | +7,888 | New |
|
|
TSS
9
Two Sigma Securities
New York
| $1K | +$1.42K | +11,141 | New |
|
|
PA
10
Perceptive Advisors
New York
| – | -$80K | -462,500 | Closed |
|
|
11
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$3K | -16,332 | Closed |
|
|
MWNA
12
Marshall Wace North America
New York
| – | +$38 | +300 | +0.2% |
|
ONSIW Hedge Fund Activity: Q3 2017 in Review
9 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) for Q3 2017, worth a combined $130K — down 76% from $542K a quarter earlier.
Fund positioning in ONSIW was balanced in Q3 2017: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $4.34K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $80K sold.
- 9 institutional investors held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) as of Q3 2017, down from 10 in Q2 2017.
- Funds reported $130K of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 stock for Q3 2017, down 76% quarter-over-quarter.
- 3 funds opened new Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 positions in Q3 2017 and 3 closed out, a net change of 0 holders.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 buyer in Q3 2017 was Virtu Financial, an estimated $4.34K added.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 seller in Q3 2017 was Perceptive Advisors, an estimated $80K sold.
Based on aggregated 13F filings for Q3 2017.